Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ERSP targets sexual supplement

This article was originally published in The Tan Sheet

Executive Summary

The Daily Wellness Company, producer of the sexual supplement ArginMax, has not responded to an initial inquiry regarding claims made in print advertising for the product, the Electronic Retailing Self-Regulation Program (ERSP) says. The claims in question include a statement touting ArginMax as the "only scientifically validated, natural nutritional supplement formula for sexual performance and enjoyment." The producers of the supposed sexual enhancer also assert ArginMax provides "88% improved ability to maintain erection[s]" and "71% improved level of sexual desire." According to ERSP protocol, Daily Wellness will be expected to provide substantiation for its core claims by Nov. 4 before ERSP refers the matter to the appropriate government agency...

The Daily Wellness Company, producer of the sexual supplement ArginMax , has not responded to an initial inquiry regarding claims made in print advertising for the product, the Electronic Retailing Self-Regulation Program (ERSP) says. The claims in question include a statement touting ArginMax as the "only scientifically validated, natural nutritional supplement formula for sexual performance and enjoyment." The producers of the supposed sexual enhancer also assert ArginMax provides "88% improved ability to maintain erection[s]" and "71% improved level of sexual desire." According to ERSP protocol, Daily Wellness will be expected to provide substantiation for its core claims by Nov. 4 before ERSP refers the matter to the appropriate government agency....

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS097453

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel